相关实验视频

Updated: May 3, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

VA-ECMO患者的短期和中期生存率:一个单一中心的经验

Artur Barshatskyi¹, Marek Vicha¹, Olga Klementova¹

¹University Hospital Olomouc, Olomouc, Czech Republic.

Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery

|April 28, 2025

概括

身体外膜氧化 (ECMO) 是严重的心脏或肺衰竭的重要救援疗法. 这项研究发现VA-ECMO的死亡率很高,没有发现患者存活的预测因素.

科学领域:

心脏病学心脏病学
肺部病理学肺部病理学
关键护理医学关键护理医学

背景情况:

身体外膜氧化 (ECMO) 是严重的心脏或呼吸系统衰竭的重要生命支持干预措施.
对于ECMO的适应症已经扩大,导致在各种患者人口统计学中使用率增加.
了解结果和患者特征对于优化ECMO治疗至关重要.

研究的目的:

评估在一个中心对静脉动脉外体膜氧化 (VA-ECMO) 的10年经验.
分析患者的结果,包括住院死亡率和生存率.
根据患者人口统计和治疗持续时间,确定潜在的生存预测因素.

主要方法:

一项回顾性单中心研究分析了114名接受VA-ECMO治疗心脏和/或呼吸系统衰竭的患者.
结果侧重于住院死亡率 (中期结果).
分析了包括年龄,性别,支持持续时间和住院时间在内的患者数据.

主要成果:

总体生存率在30天后为34.2%,90天后为28.1%,12个月后为26.3%.
患者的中位数年龄为58岁,平均支持持续时间为2.6天.
两性之间没有发现生存或结果的显著差异,也没有确定预测因素.

结论:

静脉动脉ECMO经常用于关键心肺衰竭,但与高住院死亡率有关.
根据年龄,性别,支持持续时间或住院时间,没有确定短期或中期生存的显著预测因素.
需要进一步的研究来改善VA-ECMO的结果,并确定预后因素.

关键词:

身体外膜氧化氧化住院死亡率住院死亡率中期生存率中期生存率这是短期的,短期的.

更多相关视频

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

相关概念视频

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...